Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging, Cine | 41 | 2024 | 1094 | 5.170 |
Why?
|
Heart Ventricles | 45 | 2024 | 3832 | 3.160 |
Why?
|
Tetralogy of Fallot | 26 | 2023 | 629 | 2.950 |
Why?
|
Heart Defects, Congenital | 45 | 2024 | 4697 | 2.410 |
Why?
|
Pulmonary Valve Insufficiency | 10 | 2021 | 140 | 2.070 |
Why?
|
Ventricular Function, Left | 27 | 2024 | 3928 | 2.020 |
Why?
|
Magnetic Resonance Angiography | 15 | 2021 | 1426 | 1.970 |
Why?
|
Pulmonary Valve | 13 | 2021 | 413 | 1.960 |
Why?
|
Fontan Procedure | 24 | 2023 | 805 | 1.760 |
Why?
|
Myocardial Contraction | 9 | 2019 | 1515 | 1.680 |
Why?
|
Ventricular Function, Right | 15 | 2018 | 629 | 1.680 |
Why?
|
Ventricular Dysfunction, Left | 14 | 2024 | 2136 | 1.600 |
Why?
|
Heart | 18 | 2024 | 4414 | 1.260 |
Why?
|
Pulmonary Artery | 18 | 2018 | 1935 | 1.250 |
Why?
|
Imaging, Three-Dimensional | 11 | 2024 | 4034 | 1.120 |
Why?
|
Magnetic Resonance Imaging | 68 | 2024 | 36532 | 1.120 |
Why?
|
Ventricular Dysfunction, Right | 13 | 2024 | 645 | 1.110 |
Why?
|
Myocardium | 16 | 2022 | 4760 | 1.020 |
Why?
|
Stroke Volume | 34 | 2024 | 5596 | 0.990 |
Why?
|
Cardiac Surgical Procedures | 20 | 2024 | 3675 | 0.970 |
Why?
|
Transposition of Great Vessels | 8 | 2018 | 581 | 0.960 |
Why?
|
Ventricular Septum | 2 | 2023 | 76 | 0.920 |
Why?
|
Pulmonary Atresia | 7 | 2011 | 159 | 0.920 |
Why?
|
Hypoplastic Left Heart Syndrome | 6 | 2024 | 595 | 0.910 |
Why?
|
Predictive Value of Tests | 32 | 2024 | 15398 | 0.880 |
Why?
|
Ventricular Remodeling | 10 | 2018 | 1272 | 0.870 |
Why?
|
Cardiac Imaging Techniques | 5 | 2024 | 280 | 0.830 |
Why?
|
Aortic Valve Stenosis | 7 | 2015 | 2023 | 0.820 |
Why?
|
Collateral Circulation | 4 | 2013 | 292 | 0.800 |
Why?
|
Heart Valve Prosthesis Implantation | 9 | 2020 | 1566 | 0.750 |
Why?
|
Echocardiography | 23 | 2024 | 5045 | 0.750 |
Why?
|
Echocardiography, Doppler | 10 | 2018 | 899 | 0.730 |
Why?
|
Cardiac-Gated Imaging Techniques | 3 | 2021 | 139 | 0.720 |
Why?
|
Ventricular Dysfunction | 3 | 2014 | 143 | 0.710 |
Why?
|
Coronary Circulation | 6 | 2020 | 1602 | 0.690 |
Why?
|
Respiration | 5 | 2024 | 1653 | 0.680 |
Why?
|
Child | 100 | 2024 | 80564 | 0.650 |
Why?
|
Respiratory-Gated Imaging Techniques | 2 | 2024 | 73 | 0.640 |
Why?
|
Motion | 4 | 2017 | 781 | 0.640 |
Why?
|
Coronary Vessel Anomalies | 5 | 2016 | 307 | 0.610 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2659 | 0.600 |
Why?
|
Tricuspid Valve | 3 | 2018 | 422 | 0.580 |
Why?
|
Adolescent | 94 | 2024 | 88835 | 0.580 |
Why?
|
Image Interpretation, Computer-Assisted | 9 | 2021 | 3356 | 0.580 |
Why?
|
Pulmonary Circulation | 5 | 2018 | 741 | 0.570 |
Why?
|
Child, Preschool | 68 | 2024 | 42500 | 0.570 |
Why?
|
Image Processing, Computer-Assisted | 15 | 2022 | 8923 | 0.560 |
Why?
|
Recovery of Function | 9 | 2020 | 2966 | 0.550 |
Why?
|
Ebstein Anomaly | 1 | 2018 | 106 | 0.550 |
Why?
|
Coronary Vessels | 6 | 2016 | 3096 | 0.550 |
Why?
|
Cardiovascular System | 3 | 2022 | 841 | 0.540 |
Why?
|
Sodium Channels | 11 | 2010 | 334 | 0.540 |
Why?
|
Infant | 56 | 2024 | 36386 | 0.520 |
Why?
|
Exercise Tolerance | 8 | 2019 | 841 | 0.510 |
Why?
|
Iron Overload | 3 | 2021 | 245 | 0.510 |
Why?
|
Diaphragm | 2 | 2017 | 356 | 0.500 |
Why?
|
Young Adult | 55 | 2024 | 59889 | 0.500 |
Why?
|
Ventricular Pressure | 2 | 2015 | 210 | 0.490 |
Why?
|
Aortic Coarctation | 4 | 2015 | 277 | 0.480 |
Why?
|
Diastole | 8 | 2022 | 785 | 0.480 |
Why?
|
Endocardial Cushion Defects | 1 | 2014 | 43 | 0.470 |
Why?
|
Contrast Media | 14 | 2020 | 5329 | 0.470 |
Why?
|
Retrospective Studies | 64 | 2024 | 81514 | 0.470 |
Why?
|
Reproducibility of Results | 27 | 2024 | 20124 | 0.460 |
Why?
|
Leukemia | 1 | 2022 | 1522 | 0.450 |
Why?
|
Humans | 188 | 2024 | 765968 | 0.440 |
Why?
|
Artifacts | 3 | 2024 | 1893 | 0.430 |
Why?
|
Heart Diseases | 6 | 2024 | 2821 | 0.430 |
Why?
|
Iron | 4 | 2021 | 1816 | 0.420 |
Why?
|
Health Resources | 2 | 2017 | 949 | 0.410 |
Why?
|
Pulmonary Valve Stenosis | 3 | 2018 | 164 | 0.410 |
Why?
|
Myocarditis | 2 | 2021 | 802 | 0.400 |
Why?
|
Adult | 84 | 2024 | 223044 | 0.400 |
Why?
|
Aorta | 9 | 2016 | 2028 | 0.400 |
Why?
|
Male | 115 | 2024 | 363698 | 0.390 |
Why?
|
Catheterization | 4 | 2010 | 1425 | 0.390 |
Why?
|
Iron Chelating Agents | 2 | 2014 | 142 | 0.390 |
Why?
|
Angiography | 4 | 2020 | 1581 | 0.380 |
Why?
|
Hemosiderosis | 1 | 2012 | 66 | 0.380 |
Why?
|
Heart Neoplasms | 4 | 2011 | 375 | 0.370 |
Why?
|
Observer Variation | 12 | 2018 | 2615 | 0.370 |
Why?
|
Thalassemia | 2 | 2008 | 267 | 0.360 |
Why?
|
Postoperative Care | 1 | 2017 | 1470 | 0.350 |
Why?
|
Female | 110 | 2024 | 396112 | 0.350 |
Why?
|
Blood Flow Velocity | 7 | 2012 | 1381 | 0.350 |
Why?
|
Gadolinium DTPA | 6 | 2016 | 823 | 0.340 |
Why?
|
Health Promotion | 1 | 2022 | 2208 | 0.340 |
Why?
|
Exercise | 3 | 2022 | 5937 | 0.340 |
Why?
|
Aorta, Thoracic | 6 | 2015 | 1103 | 0.330 |
Why?
|
Heart Bypass, Right | 1 | 2009 | 75 | 0.310 |
Why?
|
Algorithms | 14 | 2024 | 14071 | 0.310 |
Why?
|
Dobutamine | 1 | 2009 | 114 | 0.310 |
Why?
|
Phantoms, Imaging | 7 | 2022 | 2475 | 0.310 |
Why?
|
Time Factors | 26 | 2024 | 40065 | 0.300 |
Why?
|
Image Enhancement | 4 | 2014 | 2858 | 0.300 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 2023 | 3672 | 0.290 |
Why?
|
Fibrosis | 6 | 2018 | 2070 | 0.280 |
Why?
|
Systole | 5 | 2017 | 935 | 0.280 |
Why?
|
Propanolamines | 1 | 2007 | 163 | 0.270 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2013 | 1339 | 0.270 |
Why?
|
Electrophysiology | 2 | 2009 | 1263 | 0.260 |
Why?
|
Ion Channels | 2 | 2009 | 1045 | 0.260 |
Why?
|
Heart Septum | 1 | 2007 | 303 | 0.260 |
Why?
|
Echocardiography, Three-Dimensional | 3 | 2024 | 611 | 0.260 |
Why?
|
Exercise Test | 12 | 2018 | 2180 | 0.260 |
Why?
|
Cardiovascular Diseases | 5 | 2020 | 15652 | 0.260 |
Why?
|
Carbazoles | 1 | 2007 | 229 | 0.250 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 538 | 0.250 |
Why?
|
Heart Rate | 3 | 2021 | 4204 | 0.250 |
Why?
|
Hypertrophy, Right Ventricular | 3 | 2018 | 109 | 0.250 |
Why?
|
Diseases in Twins | 1 | 2007 | 448 | 0.240 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 2 | 2018 | 537 | 0.240 |
Why?
|
Muscular Dystrophies | 1 | 2007 | 392 | 0.240 |
Why?
|
Biomedical Research | 1 | 2020 | 3458 | 0.240 |
Why?
|
Cardiomyopathies | 2 | 2015 | 2067 | 0.240 |
Why?
|
Treatment Outcome | 34 | 2024 | 65188 | 0.240 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2016 | 855 | 0.230 |
Why?
|
Ion Channel Gating | 7 | 2012 | 428 | 0.230 |
Why?
|
Heart Septal Defects, Atrial | 4 | 2011 | 452 | 0.230 |
Why?
|
Health Care Costs | 1 | 2017 | 3242 | 0.220 |
Why?
|
Follow-Up Studies | 27 | 2021 | 39193 | 0.220 |
Why?
|
Arrhythmias, Cardiac | 4 | 2019 | 2247 | 0.210 |
Why?
|
Audiovisual Aids | 1 | 2024 | 98 | 0.210 |
Why?
|
Cardiovascular Surgical Procedures | 2 | 2015 | 193 | 0.210 |
Why?
|
Tachycardia, Ventricular | 5 | 2018 | 1310 | 0.210 |
Why?
|
Ventricular Function | 4 | 2020 | 403 | 0.200 |
Why?
|
Quality Improvement | 2 | 2017 | 3853 | 0.200 |
Why?
|
Pulsatile Flow | 2 | 2002 | 318 | 0.200 |
Why?
|
Cardiology | 3 | 2020 | 1702 | 0.200 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2006 | 477 | 0.200 |
Why?
|
Ganglia, Spinal | 6 | 2010 | 529 | 0.200 |
Why?
|
Protein-Losing Enteropathies | 1 | 2001 | 45 | 0.190 |
Why?
|
Electrocardiography | 10 | 2024 | 6404 | 0.190 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2007 | 1237 | 0.190 |
Why?
|
Hemangioma | 2 | 2011 | 723 | 0.190 |
Why?
|
Heart Transplantation | 7 | 2021 | 3310 | 0.190 |
Why?
|
Mitral Valve | 2 | 2024 | 1476 | 0.190 |
Why?
|
Heart Valve Prosthesis | 3 | 2020 | 1466 | 0.190 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2007 | 845 | 0.190 |
Why?
|
Infant, Newborn | 23 | 2016 | 26346 | 0.180 |
Why?
|
Respiratory Mechanics | 2 | 2016 | 717 | 0.180 |
Why?
|
Middle Aged | 37 | 2024 | 223009 | 0.180 |
Why?
|
Drug Discovery | 1 | 2009 | 1064 | 0.180 |
Why?
|
Prospective Studies | 19 | 2024 | 54802 | 0.180 |
Why?
|
Vascular Fistula | 1 | 2000 | 50 | 0.180 |
Why?
|
Oximetry | 1 | 2003 | 459 | 0.170 |
Why?
|
Abnormalities, Multiple | 3 | 2011 | 1424 | 0.170 |
Why?
|
Echocardiography, Doppler, Pulsed | 2 | 2011 | 68 | 0.170 |
Why?
|
Sensitivity and Specificity | 8 | 2024 | 14652 | 0.170 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2020 | 262 | 0.170 |
Why?
|
Patch-Clamp Techniques | 7 | 2014 | 918 | 0.160 |
Why?
|
Coronary Aneurysm | 1 | 2002 | 233 | 0.160 |
Why?
|
Hemodynamics | 7 | 2018 | 4184 | 0.160 |
Why?
|
Cell Line | 9 | 2009 | 15543 | 0.160 |
Why?
|
Cardiac Volume | 2 | 2010 | 196 | 0.160 |
Why?
|
Anemia | 1 | 2008 | 1511 | 0.160 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2014 | 582 | 0.160 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1731 | 0.160 |
Why?
|
Stents | 5 | 2015 | 3213 | 0.150 |
Why?
|
ROC Curve | 4 | 2018 | 3620 | 0.150 |
Why?
|
Neurons, Afferent | 4 | 2005 | 497 | 0.150 |
Why?
|
Models, Cardiovascular | 2 | 2012 | 978 | 0.150 |
Why?
|
Fibroma | 3 | 2011 | 197 | 0.150 |
Why?
|
Protein Subunits | 4 | 2012 | 939 | 0.150 |
Why?
|
Gadolinium | 4 | 2009 | 965 | 0.140 |
Why?
|
Bioprosthesis | 2 | 2020 | 589 | 0.140 |
Why?
|
Diskectomy | 1 | 2018 | 201 | 0.130 |
Why?
|
Boston | 10 | 2021 | 9338 | 0.130 |
Why?
|
Regional Blood Flow | 4 | 2012 | 1478 | 0.130 |
Why?
|
Fetal Heart | 1 | 2018 | 281 | 0.130 |
Why?
|
Risk Factors | 21 | 2024 | 74840 | 0.130 |
Why?
|
Behavior Therapy | 1 | 2022 | 884 | 0.130 |
Why?
|
Blalock-Taussig Procedure | 1 | 2016 | 60 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 622 | 0.130 |
Why?
|
Protons | 1 | 2021 | 1073 | 0.130 |
Why?
|
Databases, Factual | 6 | 2018 | 8067 | 0.130 |
Why?
|
Liver | 3 | 2021 | 7562 | 0.130 |
Why?
|
Oxygen Consumption | 6 | 2019 | 1870 | 0.130 |
Why?
|
Poisson Distribution | 1 | 2017 | 508 | 0.130 |
Why?
|
Diffusion of Innovation | 1 | 2020 | 721 | 0.130 |
Why?
|
Pulmonary Veins | 3 | 2011 | 757 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2020 | 811 | 0.120 |
Why?
|
Ultrasonography, Prenatal | 2 | 2018 | 1774 | 0.120 |
Why?
|
Vascular Surgical Procedures | 2 | 2015 | 1485 | 0.120 |
Why?
|
Marijuana Smoking | 1 | 2018 | 261 | 0.120 |
Why?
|
Coronary Angiography | 4 | 2018 | 4493 | 0.120 |
Why?
|
Radiation Protection | 1 | 2018 | 424 | 0.120 |
Why?
|
Nerve Tissue Proteins | 5 | 2010 | 4392 | 0.110 |
Why?
|
Kv1.2 Potassium Channel | 1 | 2014 | 14 | 0.110 |
Why?
|
Cross-Sectional Studies | 11 | 2022 | 26318 | 0.110 |
Why?
|
Radiography | 7 | 2013 | 6919 | 0.110 |
Why?
|
Pichia | 1 | 2014 | 47 | 0.110 |
Why?
|
Heart Failure | 5 | 2022 | 11840 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2014 | 1333 | 0.110 |
Why?
|
Blood Vessel Prosthesis | 2 | 2015 | 912 | 0.110 |
Why?
|
Hospitals, Pediatric | 4 | 2018 | 1846 | 0.110 |
Why?
|
Heart Septal Defects | 1 | 2014 | 191 | 0.110 |
Why?
|
Elasticity | 1 | 2015 | 652 | 0.110 |
Why?
|
Aequorin | 1 | 2012 | 15 | 0.100 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7425 | 0.100 |
Why?
|
Arteries | 1 | 2018 | 1118 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3100 | 0.100 |
Why?
|
Postoperative Complications | 6 | 2017 | 15747 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3223 | 0.100 |
Why?
|
Bundle-Branch Block | 1 | 2014 | 280 | 0.100 |
Why?
|
Graft Occlusion, Vascular | 1 | 1995 | 540 | 0.100 |
Why?
|
Watchful Waiting | 1 | 2016 | 493 | 0.100 |
Why?
|
Aortic Valve Insufficiency | 1 | 2016 | 575 | 0.100 |
Why?
|
Organ Size | 6 | 2015 | 2260 | 0.090 |
Why?
|
Aged | 16 | 2022 | 171117 | 0.090 |
Why?
|
Connexin 43 | 1 | 2012 | 202 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 2014 | 233 | 0.090 |
Why?
|
Feasibility Studies | 5 | 2020 | 5302 | 0.090 |
Why?
|
Prognosis | 9 | 2015 | 29922 | 0.090 |
Why?
|
High-Throughput Screening Assays | 2 | 2014 | 938 | 0.090 |
Why?
|
Membrane Potentials | 7 | 2014 | 1083 | 0.090 |
Why?
|
Fetal Diseases | 2 | 2007 | 914 | 0.090 |
Why?
|
Vena Cava, Inferior | 2 | 2011 | 463 | 0.090 |
Why?
|
Nicotinic Antagonists | 1 | 2011 | 90 | 0.090 |
Why?
|
Registries | 4 | 2018 | 8297 | 0.090 |
Why?
|
Program Evaluation | 2 | 2017 | 2499 | 0.090 |
Why?
|
Blood Pressure | 5 | 2015 | 8532 | 0.090 |
Why?
|
Computer Simulation | 2 | 2022 | 6255 | 0.090 |
Why?
|
Linear Models | 5 | 2016 | 5876 | 0.090 |
Why?
|
Multivariate Analysis | 8 | 2018 | 12056 | 0.090 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2014 | 363 | 0.090 |
Why?
|
Disease Progression | 5 | 2016 | 13632 | 0.090 |
Why?
|
Knee Injuries | 1 | 2015 | 494 | 0.090 |
Why?
|
Cicatrix | 1 | 2016 | 798 | 0.090 |
Why?
|
Sarcomeres | 1 | 2013 | 379 | 0.090 |
Why?
|
Endomyocardial Fibrosis | 1 | 2010 | 41 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8703 | 0.090 |
Why?
|
Reference Values | 3 | 2022 | 4908 | 0.080 |
Why?
|
Biological Assay | 1 | 2012 | 627 | 0.080 |
Why?
|
Brachiocephalic Trunk | 1 | 2009 | 40 | 0.080 |
Why?
|
Age Factors | 5 | 2024 | 18380 | 0.080 |
Why?
|
Hospitalization | 2 | 2021 | 10808 | 0.080 |
Why?
|
Lumbar Vertebrae | 1 | 2018 | 1873 | 0.080 |
Why?
|
Aortic Stenosis, Supravalvular | 1 | 2008 | 28 | 0.080 |
Why?
|
Public Health | 1 | 2022 | 2680 | 0.080 |
Why?
|
Equipment Design | 4 | 2018 | 3481 | 0.080 |
Why?
|
Ectopia Cordis | 1 | 2008 | 5 | 0.080 |
Why?
|
Arthroscopy | 1 | 2015 | 966 | 0.080 |
Why?
|
Risk Assessment | 9 | 2024 | 24282 | 0.080 |
Why?
|
Palliative Care | 3 | 2013 | 3645 | 0.070 |
Why?
|
Recombinant Proteins | 4 | 2014 | 6493 | 0.070 |
Why?
|
Calcium Signaling | 1 | 2012 | 733 | 0.070 |
Why?
|
Protein Isoforms | 2 | 2010 | 1718 | 0.070 |
Why?
|
Receptors, Nicotinic | 1 | 2011 | 494 | 0.070 |
Why?
|
Area Under Curve | 3 | 2018 | 1638 | 0.070 |
Why?
|
Rhabdomyoma | 2 | 2011 | 56 | 0.070 |
Why?
|
Electrophysiological Phenomena | 1 | 2009 | 307 | 0.070 |
Why?
|
Disease-Free Survival | 2 | 2014 | 6832 | 0.070 |
Why?
|
Receptors, Purinergic P2 | 1 | 2008 | 149 | 0.070 |
Why?
|
Tissue Array Analysis | 1 | 2009 | 545 | 0.070 |
Why?
|
Patient Care Management | 1 | 2010 | 303 | 0.070 |
Why?
|
Locomotion | 1 | 1989 | 384 | 0.070 |
Why?
|
Equipment and Supplies | 1 | 1989 | 273 | 0.070 |
Why?
|
Heart Aneurysm | 1 | 2007 | 115 | 0.070 |
Why?
|
Patient Care Planning | 1 | 2012 | 906 | 0.070 |
Why?
|
Critical Pathways | 1 | 2010 | 474 | 0.070 |
Why?
|
Survival Rate | 4 | 2018 | 12795 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2535 | 0.070 |
Why?
|
Heart Atria | 3 | 2018 | 1363 | 0.070 |
Why?
|
Vascular Resistance | 1 | 2009 | 941 | 0.060 |
Why?
|
Canada | 3 | 2020 | 2119 | 0.060 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1403 | 0.060 |
Why?
|
GTP-Binding Protein gamma Subunits | 1 | 2005 | 22 | 0.060 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2005 | 34 | 0.060 |
Why?
|
Neuropeptides | 2 | 2001 | 951 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4255 | 0.060 |
Why?
|
Endocardial Fibroelastosis | 1 | 2005 | 66 | 0.060 |
Why?
|
Receptors, GABA-A | 1 | 2009 | 624 | 0.060 |
Why?
|
Heart Valve Diseases | 1 | 2012 | 1030 | 0.060 |
Why?
|
Teratoma | 2 | 2011 | 401 | 0.060 |
Why?
|
United States | 9 | 2021 | 72903 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 2 | 2012 | 1568 | 0.060 |
Why?
|
Odds Ratio | 5 | 2016 | 9649 | 0.060 |
Why?
|
Severity of Illness Index | 5 | 2017 | 15880 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2014 | 10729 | 0.060 |
Why?
|
Prenatal Diagnosis | 2 | 2010 | 1268 | 0.060 |
Why?
|
Hospital Costs | 1 | 2010 | 956 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6499 | 0.060 |
Why?
|
Software | 1 | 2017 | 4462 | 0.050 |
Why?
|
Capsaicin | 1 | 2004 | 226 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 10383 | 0.050 |
Why?
|
Tetrodotoxin | 2 | 2002 | 244 | 0.050 |
Why?
|
Monitoring, Physiologic | 2 | 2008 | 1792 | 0.050 |
Why?
|
Logistic Models | 5 | 2018 | 13266 | 0.050 |
Why?
|
Thoracic Duct | 1 | 2023 | 71 | 0.050 |
Why?
|
Transducers | 2 | 2018 | 239 | 0.050 |
Why?
|
Cohort Studies | 8 | 2022 | 41649 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5881 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2008 | 1999 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2243 | 0.050 |
Why?
|
Postoperative Period | 3 | 2012 | 1816 | 0.050 |
Why?
|
Hemangioma, Capillary | 1 | 2002 | 64 | 0.050 |
Why?
|
Prosthesis Design | 2 | 2020 | 2105 | 0.050 |
Why?
|
Dilatation, Pathologic | 2 | 2016 | 527 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2015 | 2222 | 0.050 |
Why?
|
Neuralgia | 2 | 2005 | 625 | 0.050 |
Why?
|
Polyvinyls | 1 | 2002 | 153 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2014 | 22223 | 0.040 |
Why?
|
Coronary Stenosis | 2 | 2008 | 800 | 0.040 |
Why?
|
Anesthesia, General | 2 | 2007 | 1172 | 0.040 |
Why?
|
Metals | 1 | 2005 | 710 | 0.040 |
Why?
|
Transfection | 5 | 2008 | 5743 | 0.040 |
Why?
|
Tissue Engineering | 1 | 2010 | 1855 | 0.040 |
Why?
|
Myocardial Infarction | 3 | 2018 | 11499 | 0.040 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2003 | 290 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 326 | 0.040 |
Why?
|
Rats | 7 | 2014 | 23707 | 0.040 |
Why?
|
Animals | 12 | 2020 | 168764 | 0.040 |
Why?
|
Calcium | 1 | 2012 | 5767 | 0.040 |
Why?
|
HEK293 Cells | 3 | 2014 | 4260 | 0.040 |
Why?
|
Equipment Failure | 2 | 2006 | 578 | 0.040 |
Why?
|
Thorax | 1 | 2022 | 554 | 0.040 |
Why?
|
Anastomosis, Surgical | 2 | 2016 | 990 | 0.040 |
Why?
|
Sheep | 2 | 2013 | 1440 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1409 | 0.040 |
Why?
|
Brain Chemistry | 1 | 2002 | 952 | 0.040 |
Why?
|
Aortography | 1 | 2000 | 414 | 0.040 |
Why?
|
Prostheses and Implants | 1 | 2005 | 1273 | 0.040 |
Why?
|
Troponin | 1 | 2021 | 533 | 0.040 |
Why?
|
Heart Rate, Fetal | 1 | 2018 | 78 | 0.040 |
Why?
|
Veins | 1 | 2002 | 764 | 0.040 |
Why?
|
Anesthesia | 1 | 2008 | 1590 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2014 | 13400 | 0.040 |
Why?
|
Cardiac Output | 1 | 2000 | 840 | 0.040 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.030 |
Why?
|
Radiographic Image Enhancement | 1 | 2002 | 872 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 6 | 2023 | 20659 | 0.030 |
Why?
|
Ohio | 1 | 2017 | 320 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2003 | 2352 | 0.030 |
Why?
|
Electric Stimulation | 3 | 2008 | 1735 | 0.030 |
Why?
|
Length of Stay | 3 | 2021 | 6485 | 0.030 |
Why?
|
Troponin T | 1 | 2022 | 785 | 0.030 |
Why?
|
Kentucky | 1 | 2016 | 83 | 0.030 |
Why?
|
Ontario | 1 | 2017 | 402 | 0.030 |
Why?
|
Delphi Technique | 1 | 2020 | 893 | 0.030 |
Why?
|
Probability | 1 | 2001 | 2475 | 0.030 |
Why?
|
Research Design | 3 | 2024 | 6209 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1915 | 0.030 |
Why?
|
Europe | 2 | 2013 | 3423 | 0.030 |
Why?
|
Stainless Steel | 1 | 2015 | 79 | 0.030 |
Why?
|
Germany | 1 | 2018 | 882 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3529 | 0.030 |
Why?
|
Neuroblastoma | 1 | 2004 | 1263 | 0.030 |
Why?
|
American Heart Association | 1 | 2020 | 1047 | 0.030 |
Why?
|
Scotland | 1 | 2015 | 115 | 0.030 |
Why?
|
Incidence | 5 | 2015 | 21480 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 4 | 2011 | 8102 | 0.030 |
Why?
|
Cardiomegaly | 1 | 2018 | 589 | 0.030 |
Why?
|
Hypertension | 1 | 2015 | 8626 | 0.030 |
Why?
|
Sweden | 1 | 2018 | 1381 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2001 | 1162 | 0.030 |
Why?
|
Heart Function Tests | 1 | 2015 | 317 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2020 | 1191 | 0.030 |
Why?
|
Aftercare | 1 | 2020 | 911 | 0.030 |
Why?
|
Mitral Valve Insufficiency | 1 | 2024 | 1414 | 0.030 |
Why?
|
Norwood Procedures | 1 | 2016 | 192 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 2014 | 4165 | 0.030 |
Why?
|
Rupture | 1 | 2015 | 443 | 0.030 |
Why?
|
Regression Analysis | 1 | 2003 | 6322 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2014 | 17594 | 0.030 |
Why?
|
Survivors | 1 | 2004 | 2372 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2002 | 6203 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2022 | 1736 | 0.030 |
Why?
|
Flow Injection Analysis | 1 | 2012 | 21 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2233 | 0.030 |
Why?
|
Cerebellum | 1 | 2000 | 1518 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.030 |
Why?
|
Luminescent Agents | 1 | 2012 | 30 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2652 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2014 | 541 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2000 | 1456 | 0.030 |
Why?
|
Comorbidity | 1 | 2007 | 10563 | 0.030 |
Why?
|
Neuronal Plasticity | 1 | 2001 | 1445 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2015 | 993 | 0.020 |
Why?
|
Binding Sites | 2 | 2012 | 6001 | 0.020 |
Why?
|
Models, Molecular | 2 | 2012 | 5379 | 0.020 |
Why?
|
Nocardia | 1 | 1991 | 10 | 0.020 |
Why?
|
Medical History Taking | 1 | 2015 | 777 | 0.020 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 269 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1668 | 0.020 |
Why?
|
Angioplasty, Balloon | 1 | 2015 | 608 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2018 | 1820 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2014 | 438 | 0.020 |
Why?
|
Pregnancy | 3 | 2008 | 30260 | 0.020 |
Why?
|
Codon | 1 | 2012 | 595 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3202 | 0.020 |
Why?
|
Disulfides | 1 | 2012 | 462 | 0.020 |
Why?
|
Netherlands | 1 | 2015 | 2277 | 0.020 |
Why?
|
CHO Cells | 2 | 2004 | 1372 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2012 | 446 | 0.020 |
Why?
|
Circular Dichroism | 1 | 2010 | 331 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 834 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2018 | 1944 | 0.020 |
Why?
|
Echocardiography, Stress | 1 | 2010 | 137 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2004 | 11888 | 0.020 |
Why?
|
Cricetinae | 2 | 2004 | 2411 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3432 | 0.020 |
Why?
|
Flumazenil | 1 | 2009 | 84 | 0.020 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2009 | 58 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2022 | 5125 | 0.020 |
Why?
|
Physical Examination | 1 | 2015 | 1266 | 0.020 |
Why?
|
GABA-A Receptor Agonists | 1 | 2009 | 86 | 0.020 |
Why?
|
Up-Regulation | 2 | 2010 | 4137 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2018 | 59489 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2014 | 741 | 0.020 |
Why?
|
Gestational Age | 1 | 2018 | 3609 | 0.020 |
Why?
|
Antibody Specificity | 2 | 2001 | 1061 | 0.020 |
Why?
|
Heart Conduction System | 1 | 2014 | 1006 | 0.020 |
Why?
|
Receptors, Purinergic P2X2 | 1 | 2008 | 8 | 0.020 |
Why?
|
Preoperative Care | 2 | 2013 | 2267 | 0.020 |
Why?
|
Coronary Disease | 2 | 2002 | 5912 | 0.020 |
Why?
|
Radiation | 1 | 2008 | 48 | 0.020 |
Why?
|
Phosphorus Isotopes | 1 | 2008 | 125 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3051 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2010 | 433 | 0.020 |
Why?
|
Cardiology Service, Hospital | 1 | 2010 | 242 | 0.020 |
Why?
|
Azides | 1 | 2008 | 120 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3956 | 0.020 |
Why?
|
Pain Measurement | 1 | 2018 | 3561 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1772 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1377 | 0.020 |
Why?
|
Anaerobic Threshold | 1 | 2007 | 51 | 0.020 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 499 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2012 | 959 | 0.020 |
Why?
|
Hippocampus | 1 | 2000 | 3775 | 0.020 |
Why?
|
Biophysical Phenomena | 1 | 2008 | 318 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2010 | 1210 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2014 | 14751 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1989 | 1600 | 0.020 |
Why?
|
Cell Separation | 1 | 2012 | 1718 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 858 | 0.020 |
Why?
|
Blotting, Western | 2 | 2004 | 5020 | 0.020 |
Why?
|
Williams Syndrome | 1 | 2008 | 196 | 0.020 |
Why?
|
Models, Animal | 1 | 2013 | 2120 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3067 | 0.020 |
Why?
|
Heterozygote | 1 | 2013 | 2794 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1192 | 0.020 |
Why?
|
Neuritis | 1 | 2005 | 35 | 0.020 |
Why?
|
Office Visits | 1 | 2010 | 595 | 0.020 |
Why?
|
Tibial Nerve | 1 | 2005 | 55 | 0.020 |
Why?
|
Sural Nerve | 1 | 2005 | 105 | 0.020 |
Why?
|
Peroneal Nerve | 1 | 2005 | 80 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 2010 | 1137 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2411 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2000 | 12768 | 0.020 |
Why?
|
Tendons | 1 | 1989 | 555 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2009 | 1589 | 0.020 |
Why?
|
Cost Savings | 1 | 2010 | 904 | 0.010 |
Why?
|
Massachusetts | 2 | 2012 | 8875 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 1978 | 0.010 |
Why?
|
Muscles | 1 | 1989 | 1578 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1145 | 0.010 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2004 | 39 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2010 | 2669 | 0.010 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2010 | 669 | 0.010 |
Why?
|
Electric Conductivity | 1 | 2005 | 403 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2012 | 1889 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1275 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2000 | 5767 | 0.010 |
Why?
|
Program Development | 1 | 2010 | 1295 | 0.010 |
Why?
|
Tissue Survival | 1 | 2004 | 121 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2010 | 1315 | 0.010 |
Why?
|
Electric Countershock | 1 | 2006 | 534 | 0.010 |
Why?
|
Neuroma | 1 | 2005 | 137 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2008 | 1831 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2009 | 1136 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 1988 | 623 | 0.010 |
Why?
|
Sodium Channel Blockers | 1 | 2004 | 170 | 0.010 |
Why?
|
Health Services Research | 1 | 2010 | 1808 | 0.010 |
Why?
|
Cricetulus | 1 | 2004 | 805 | 0.010 |
Why?
|
Aortic Valve | 1 | 2012 | 1968 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2014 | 3681 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 3737 | 0.010 |
Why?
|
Benzazepines | 1 | 2004 | 308 | 0.010 |
Why?
|
Medication Adherence | 1 | 2014 | 2192 | 0.010 |
Why?
|
Infant Welfare | 1 | 2002 | 78 | 0.010 |
Why?
|
Neurofilament Proteins | 1 | 2004 | 337 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7584 | 0.010 |
Why?
|
Kidney | 3 | 2002 | 7066 | 0.010 |
Why?
|
Potassium Channels | 1 | 2004 | 534 | 0.010 |
Why?
|
Hepatic Veins | 1 | 2002 | 112 | 0.010 |
Why?
|
Hyperalgesia | 1 | 2005 | 514 | 0.010 |
Why?
|
Mutation | 3 | 2013 | 30198 | 0.010 |
Why?
|
Molecular Biology | 1 | 2005 | 574 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10070 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16721 | 0.010 |
Why?
|
Mutagenesis | 1 | 2005 | 1228 | 0.010 |
Why?
|
Vena Cava, Superior | 1 | 2002 | 198 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2004 | 1467 | 0.010 |
Why?
|
Potassium | 1 | 2004 | 1311 | 0.010 |
Why?
|
Xenopus laevis | 1 | 2004 | 964 | 0.010 |
Why?
|
Muscle Proteins | 1 | 2005 | 1158 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12509 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2003 | 1105 | 0.010 |
Why?
|
Brachial Plexus | 1 | 2001 | 174 | 0.010 |
Why?
|
Bone and Bones | 1 | 1989 | 2554 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1984 | 0.010 |
Why?
|
Neurons | 2 | 2010 | 9525 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 1673 | 0.010 |
Why?
|
Oxygen | 1 | 2010 | 4241 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15842 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3750 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 2008 | 2128 | 0.010 |
Why?
|
Child Welfare | 1 | 2002 | 521 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2005 | 1865 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13039 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2010 | 2418 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2006 | 1490 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2001 | 2476 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2002 | 12976 | 0.010 |
Why?
|
Protein Binding | 1 | 2008 | 9296 | 0.010 |
Why?
|
Chronic Disease | 1 | 2010 | 9347 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 2002 | 1015 | 0.010 |
Why?
|
Inpatients | 1 | 2007 | 2564 | 0.010 |
Why?
|
Clinical Competence | 1 | 2010 | 4863 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 3807 | 0.010 |
Why?
|
Health Status | 1 | 2007 | 4080 | 0.010 |
Why?
|
Body Weight | 1 | 2004 | 4622 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2005 | 2511 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1991 | 7478 | 0.010 |
Why?
|
Pyrimidines | 1 | 2004 | 3047 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1991 | 211 | 0.010 |
Why?
|
Fermentation | 1 | 1991 | 141 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11022 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2005 | 14448 | 0.010 |
Why?
|
Hydrolysis | 1 | 1991 | 642 | 0.010 |
Why?
|
Lipolysis | 1 | 1991 | 211 | 0.010 |
Why?
|
Culture Media | 1 | 1991 | 890 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2004 | 17075 | 0.000 |
Why?
|
DNA, Bacterial | 1 | 1991 | 1477 | 0.000 |
Why?
|
Pyridones | 1 | 1991 | 816 | 0.000 |
Why?
|
Pulmonary Edema | 1 | 1988 | 412 | 0.000 |
Why?
|
Amino Acids | 1 | 1991 | 1709 | 0.000 |
Why?
|
Triglycerides | 1 | 1991 | 2441 | 0.000 |
Why?
|
Glucose | 1 | 1991 | 4335 | 0.000 |
Why?
|
Mice | 1 | 2005 | 81819 | 0.000 |
Why?
|
Bacterial Proteins | 1 | 1991 | 3837 | 0.000 |
Why?
|